Jim Simons Sellas Life Sciences Group, Inc. Transaction History

Renaissance Technologies LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$1.08 - $1.39 $65,330 - $84,082	60,491 Added 186.44%	92,937 $116,000
Q2 2024 Aug 09, 2024	BUY	$1.06 - $1.63 $34,392 - $52,886	32,446 New	32,446 $38,000
Q4 2023 Feb 13, 2024	BUY	$0.88 - $1.57 $44,352 - $79,128	50,400 New	50,400 $53,000
Q3 2022 Nov 14, 2022	SELL	$2.02 - $3.38 $23,104 - $38,660	-11,438 Reduced 33.8%	22,400 $45,000
Q2 2022 Aug 12, 2022	BUY	$2.14 - $4.15 $72,413 - $140,427	33,838 New	33,838 $75,000
Q3 2020 Nov 13, 2020	SELL	$1.88 - $3.58 $26,996 - $51,408	-14,360 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$1.53 - $3.93 $21,970 - $56,434	14,360 New	14,360 $42,000

6.49M

1.8M

49.7K

Ticker SLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,551,900
Market Cap $24.5M
Description
SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the tr...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.